Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

27 Jul 2026, 22:51 UTC · 3h ago

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Medtronic (MDT) is currently assigned a Zacks Rank #4 (Sell). — The Zacks Rank is a quantitative model correlated with near-term price action, and a 'Sell' rating suggests negative short-term outlook.
-0.60
2
Medtronic is projected to report quarterly earnings on September 1, 2026, with an expected EPS of $1.39 and revenue of $9.48 billion. — Projected growth of ~10% in both EPS and revenue relative to the prior year is fundamentally positive, though markets will react to the actual beat/miss.
+0.30
3
Medtronic's Forward P/E ratio of 14 is at a discount compared to its industry average of 19.1. — Trading at a discount to peers can suggest the stock is undervalued, providing a potential floor for the price.
+0.20